Dextropropoxyphene Pellets

(Product under development)
Dextropropoxyphene PelletsDextropropoxyphene, manufactured is an analgesic in the opioid category. It is intended to treat mild pain and has, in addition, anti-tussive and local anesthetic effects.

It has been taken off the market in Europe and the US due to concerns of fatal overdoses and arrhythmias. An estimated 10 million patients have used these products.

Dextropropoxyphene is sometimes combined with paracetamol or acetylsalicylic acid. Trade-names include Darvocet-N and Di-Gesic Darvon with APAP for dextropropoxyphene and paracetamol and Darvon with ASA for dextropropoxyphene and aspirin.

The British Approved Name (i.e. the generic name of the active ingredient) of the paracetamol/dextropropoxyphene preparation is co-proxamol (sold under a variety of brand names); however, it has been withdrawn since 2007, and is no longer available to new patients.

The paracetamol combination(s) are known as Capadex or Di-Gesic in Australia, Lentogesic in South Africa, and Di-Antalvic in France (unlike co-proxamol, which is an approved name, these are all brand names).

Available Forms:
Dextropropoxyphene Pellets
Dextropropoxyphene Granulers

Umang Pharmatech equipments used for production of Dextropropoxyphene Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Dextropropoxyphene Pellets
Systematic (IUPAC) name
Dextropropoxyphene Pellets
Identifiers
Dextropropoxyphene Pellets
Chemical data
(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate
CAS number : 469-62-5
ATC code : N02AC04
PubChem : CID 10100
DrugBank : DB00647
ChemSpider : 9696
UNII : S2F83W92TK
KEGG : D07809
ChEBI : CHEBI:51173
ChEMBL : CHEMBL1213351
Formula : C22H29NO2
Mol. mass : 339.471 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL